General information

Announcements(2)

Program

Sessions

Search presentations

Download PDF for print

Timetable

Mon. Mar 16, 2026

Tue. Mar 17, 2026

Wed. Mar 18, 2026

web_header.png

web_icon.png

Change account information such as the email address and password on the account setting screen common to Confit.

Login required to view

Password required to view

Presentation Information

Session Details

Enter the password to view the abstracts.<br>The password will be emailed to those who have completed the registration.

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Program Type

Announcements

Profile management

Bookmark

Current status and prospects of anti-amyloid therapy

While cancer treatment has made revolutionary progress over the past decade, development of drugs in the field of neurology remains a major challenge for us. In particular, there has been no groundbreaking treatment for Alzheimer's disease so far. In recent years, Lecanemab and Donanemab, which work by removing amyloid-beta plaques, have been approved, marking a new phase in Alzheimer's disease treatment. In this symposium, we will present the latest research, including the outlook for novel drugs improvements in dementia independent of amyloid-beta, changes in endothelial cells in the Alzheimer's disease brain and their relation to amyloid-beta, as well as clinical development strategies for novel therapies.

The 99th Annual Meeting of the Japanese Pharmacological Society

Presentation Information

[1-S-04]Current status and prospects of anti-amyloid therapy

Keywords:

Password required to view

Comment